Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibitionFrancesca Megiorni, Carlo Dominici|Journal of Experimental & Clinical Cancer Research|2015Cited by 55
DNMT3B<i>in vitro</i>knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiationFrancesca Megiorni, Carlo Dominici|Oncotarget|2016Cited by 40
Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic TumorsStefania Uccini, Carlo Dominici|Clinical Cancer Research|2005Cited by 38
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell linesSimona Camero, Carlo Dominici|Journal of Cancer Research and Clinical Oncology|2018Cited by 35